CompaniesInimex Pharmaceuticals

Inimex Pharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

4

As Collaborator

1

Total Enrollment

335

By Phase

PHASE2: 1PHASE1: 3

By Status

COMPLETED: 3ACTIVE_NOT_RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
NCT01705002
Hover over trial bars to see details

Recent Trials

NCT06478862Lead Sponsor
Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy
PHASE2Active, not recruiting
20 participants
Started: Jun 13, 2024 · Completed: Jan 31, 2027
NCT04729205Lead Sponsor
Assessment of Safety and Therapeutic Efficacy of Promitil in Combination With Folfox in Patients With GI Malignancies
PHASE1Terminated
9 participants
Started: Jan 13, 2021 · Completed: Sep 12, 2023
NCT03823989Lead Sponsor
Intravenously Administered Liposomal PROMITIL in Combination With External Beam Radiotherapy in Cancer Patients
PHASE1Completed
18 participants
Started: Jan 3, 2019 · Completed: Dec 30, 2021
NCT01705002Lead Sponsor
Intravenously Administered Pegylated Liposomal Mitomycin-C Lipid-based Prodrug (PROMITIL) in Cancer Patients With Solid Tumors.
PHASE1Completed
88 participants
Started: Oct 31, 2012 · Completed: Jun 30, 2018
NCT00351234Collaborator
Carnitine Levels and Carnitine Supplementation in Type I Diabetes
N/ACompleted
200 participants
Started: Oct 31, 2004 · Completed: Apr 30, 2007